Eukles Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.71M Buy
53,715
+2,403
+5% +$166K 1.52% 18
2025
Q1
$3.56M Buy
51,312
+1,667
+3% +$116K 1.56% 20
2024
Q4
$4.27M Sell
49,645
-3,939
-7% -$339K 1.82% 14
2024
Q3
$6.38M Sell
53,584
-371
-0.7% -$44.2K 2.56% 9
2024
Q2
$7.7M Sell
53,955
-378
-0.7% -$54K 3.33% 5
2024
Q1
$6.98M Sell
54,333
-1,598
-3% -$205K 3.03% 6
2023
Q4
$5.79M Sell
55,931
-2,754
-5% -$285K 2.74% 8
2023
Q3
$5.34M Buy
58,685
+415
+0.7% +$37.7K 2.82% 7
2023
Q2
$4.71M Buy
58,270
+58
+0.1% +$4.69K 2.41% 8
2023
Q1
$4.63M Sell
58,212
-540
-0.9% -$43K 2.52% 8
2022
Q4
$3.98M Buy
58,752
+408
+0.7% +$27.6K 2.32% 12
2022
Q3
$2.91M Sell
58,344
-186
-0.3% -$9.26K 1.9% 14
2022
Q2
$3.26M Buy
58,530
+182
+0.3% +$10.1K 2.06% 14
2022
Q1
$3.24M Sell
58,348
-658
-1% -$36.5K 1.76% 17
2021
Q4
$3.3M Buy
59,006
+1,120
+2% +$62.7K 1.6% 20
2021
Q3
$2.78M Buy
57,886
+1,990
+4% +$95.5K 1.52% 25
2021
Q2
$2.34M Buy
55,896
+3,986
+8% +$167K 1.3% 29
2021
Q1
$1.75M Buy
51,910
+1,122
+2% +$37.8K 1.13% 37
2020
Q4
$1.77M Buy
50,788
+1,204
+2% +$42.1K 1.23% 34
2020
Q3
$1.72M Buy
49,584
+598
+1% +$20.8K 1.34% 31
2020
Q2
$1.6M Buy
48,986
+2,894
+6% +$94.7K 1.36% 31
2020
Q1
$1.39M Sell
46,092
-2,082
-4% -$62.7K 1.45% 27
2019
Q4
$1.39M Sell
48,174
-494
-1% -$14.3K 1.14% 38
2019
Q3
$1.26M Sell
48,668
-138
-0.3% -$3.57K 1.09% 41
2019
Q2
$1.25M Sell
48,806
-238
-0.5% -$6.08K 1.08% 40
2019
Q1
$1.28M Buy
49,044
+196
+0.4% +$5.13K 1.17% 40
2018
Q4
$1.13M Buy
+48,848
New +$1.13M 1.17% 40